Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-04

Clinical Trial Update: A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication

View source ↗

Summary

This completed clinical trial evaluated producing technetium-99m pertechnetate in a high-energy cyclotron for use in thyroid scans in patients with autoimmune t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Technetium-99m pertechnetate (technetium-99m pertechnetate)

Snippet

Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Conditions: Autoimmune Thyroid Disease, Congenital Hypothyroidism | Status: COMPLETED